MedPath

Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial

Not Applicable
Completed
Conditions
Lung Cancer
Registration Number
NCT00665912
Lead Sponsor
Zimmer Biomet
Brief Summary

The purpose of this study is to determine whether the use of platelet-rich plasma (PRP) and concentrated platelet-poor plasma (PPPc) can reduce the duration of post-operative air leak after lobectomy for lung tumours.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
204
Inclusion Criteria
  • Patients requiring a lobectomy
Exclusion Criteria
  • Pneumonectomy
  • Sleeve lobectomy
  • Determination of unresectability (prior to the initiation of lobectomy)
  • Wedge resection alone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Duration of postoperative air leakEvery 4 hours of postop hospital stay, between 4-6 weeks postop
Secondary Outcome Measures
NameTimeMethod
Incidence of air leak, Prolonged air leak (> days), ComplicationsEvery 4 hours of postop hospital stay, between 4-6 weeks postop

Trial Locations

Locations (1)

University of Western Ontario: Division of Thoracic Surgery

🇨🇦

London, Ontario, Canada

University of Western Ontario: Division of Thoracic Surgery
🇨🇦London, Ontario, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.